Medical Affairs has changed significantly in the last 20 years. Once considered a scientific support function primarily, Medical Affairs organizations are now seen as strategic assets across pharmaceutical, biotechnology, and medical device companies. Modern Medical Affairs teams contribute to clinical strategy, evidence generation and external engagement, market access, patient-centric activities, and internal decision-making. It takes much more than medical science to excel.
Medical Affairs leaders need to be strategic executives. They need to translate science into strategy for the organization. They need to build high-performing cross-functional teams. They need to earn credibility with stakeholders inside and outside the organization. They need to understand and respond to an increasingly complex regulatory environment. And they need to lead and influence across commercial, clinical development, market access, regulatory affairs, and executive leadership functions. These are leadership skills; they are not degree-specific skills.
There are excellent Medical Affairs leaders throughout the industry with PharmD, MD, and PhD degrees.
Physicians often have a depth of clinical expertise and first-hand patient care experience. PharmDs often have deep knowledge and experience in pharmacotherapy, medical/scientific exchange, medical information, and healthcare systems. PhDs have rigorous scientific thinking, translational expertise, and knowledge of evidence generation.

The highest-performing organizations are the ones that define leadership by ability, not by achievement. They hire executives who can shape strategy, build influence, generate organizational alignment, develop the next generation of leaders, and deliver quantifiable results. Scientific expertise is still table stakes. But credibility will come from expertise, judgment, and a track record of execution – not from an MD next to your name.
That doesn’t mean doctors can’t be leaders. In fact, in certain therapeutic areas – especially ones that require deeply specialized clinical expertise or involve particularly nuanced scientific discussions – an MD is likely the best candidate. What it does mean is we should stop leaning on automatic assumptions.
Boards, executive teams, and hiring managers should start with a new question. Instead of “Does this candidate have an MD?” they should ask, “Does this person have the skill set to propel Medical Affairs into its next chapter?”
That simple change shifts the dialogue. The next Head of Medical Affairs will need to navigate medical affairs through scientific complexity, rising regulatory expectations, digital disruption, real-world evidence, and escalating demands from patients, physicians, and health systems.
Experience, executive presence, strategic mindset, organizational reach, and talent development are now table stakes alongside scientific acumen.
Choosing who should lead Medical Affairs shouldn’t be a checkbox exercise. It should be a skills-based decision.
We’ve talked a lot about diversity of thought over the years. Great decisions are made when organizations allow for different viewpoints to be considered. Medical Affairs should be no different. When we think broadly about who has the skills and ability to lead Medical Affairs, we open the door for more candidates, create stronger leadership pipelines, and build organizations better suited to drive science forward and improve outcomes for patients.

